ConceptioArchiveClinicalTrials.gov
ClinicalTrials.govpublic full text

A Open Label, Dose Escalating Study to Evaluate the Safety and Tolerability of Ascending Intravenous (i.v.) Doses of Catumaxomab in Epithelial Cancer Patients

Neovii Biotech · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
cancercarcinomamonoclonal-antibody
epithelial cancer patients, cancer, neoplasm, carcinoma, intravenous, monoclonal antibody, removab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 831875
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.